Search over 3,000 reports

    Eviplera- Drug Insights, 2017

    Eviplera- Drug Insights, 2017
    Date: Nov, 2017
    Type: Pharmaceutical Industry Report
    Pages: 35
    Geography: Global
    Delivery Timeline: 48 hours
    SKU: DIDI0353
    DelveInsight's pharmaceuticals report, " Eviplera Drug Insights, 2017" highlights the Drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Eviplera covering the historical global sales and also provides the Eviplera sales estimation during the forecasted period (2017-2019). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Eviplera and emerging therapies in this space.


    A review of the Eviplera, based on information derived from company and industry-specific sources
    Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
    Coverage of the Drug Master Files and API Manufacturers by country
    Patent Expiry Timeline and Exclusivity Details
    Route of Synthesis of the API
    Forecasted Sales Figure from 2017-2019
    Market competition and emerging therapies
    SWOT Analysis
    DelveInsight Report Introduction
    Eviplera- Overview
    Product Description
    Route of Synthesis
    Mechanism of Action
    Adverse Reactions
    Regulatory Milestones by Region
    Deals and Partnerships
    Product Details
    Eviplera Sales Assessment
    Historical Sales
    Forecasted Sales
    Patent Details by Region
    Company Financials
    Market Competition
    Emerging Therapies*
    Drug 1
    Product Description
    Research and Development
    Product Development Activities
    SWOT Analysis
    Consulting Services
    About DelveInsight
    Contact Us
    Table 1: Eviplera, Description
    Table 2: Eviplera, Product Details
    Table 3: Eviplera, Historical Sales (in million USD)
    Table 4: Eviplera, Forecasted Sales from 2017-2019 (in million USD)
    Table 5: Eviplera, Patent Details
    Table 6: Company, Overview
    Table 7: Eviplera Major Competitors Eviplera
    Table 8: Emerging Therapies
    Figure 1: Eviplera, Historical Sales (in million USD)
    Figure 2: Eviplera, Forecasted Sales from 2017-2019 (in million USD)
    Gilead Sciences International Ltd
    human immunodeficiency virus type 1
    HIV1 infection
    Eviplera Marketed Drugs Overview
    Eviplera Market Assessment
    Eviplera API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers
    Eviplera US DMF
    Eviplera US Drug Master Files
    Eviplera Active Substance Master File/ EUDMF
    Eviplera Generic players
    Eviplera Patent Expiration
    Eviplera Patent Exclusivity
    Eviplera API Manufacturers
    Eviplera Global Forecasted Sales Figure
    Eviplera API Route of Synthesis
    Eviplera Market sales
    Eviplera SWOT Analysis
    Eviplera Pipeline
    • Single User License
      (20% Off)
    • Site License
      (30% Off)
    • Global License
      (40% Off)

    Contact Us

    +91-11-45689769, +91 9650213330


    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap